Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli.
Stein, P E; Boodhoo, A; Tyrrell, G J; Brunton, J L; Read, R J.
; 355(6362): 748-50, 1992 Feb 20.
Artigo em Inglês | MEDLINE | ID: mdl-1741063
Shiga toxin glycosphingolipid receptors and their lipid membrane ensemble in primary human blood-brain barrier endothelial cells.
Crystallization of the B chain of Shiga-like toxin I from Escherichia coli.
Functional analyses of the UDP-galactose transporter SLC35A2 using the binding of bacterial Shiga toxins as a novel activity assay.
A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.
A simple method for expression and purification of Shiga toxin 1 (Stx1) with biological activities by using a single-promoter vector and native signal peptide.
Crystallization and preliminary X-ray crystallographic analysis of verotoxin-1 B-subunit.
Identification of a peptide-based neutralizer that potently inhibits both Shiga toxins 1 and 2 by targeting specific receptor-binding regions.
Recognition of human milk oligosaccharides by bacterial exotoxins.
Shiga toxin-glycosphingolipid interaction: Status quo of research with focus on primary human brain and kidney endothelial cells.
Change in conformation with reduction of alpha-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1.